杞菊地黄丸治疗早期年龄相关性白内障临床观察

发布时间：2019-01-01 12:42

【摘要】：目的:观察杞菊地黄丸治疗早期年龄相关性白内障临床疗效。方法:研究对象为2015年7月~2016年6月在我院眼科诊治的110例早期年龄相关性白内障患者,随机分为2组,对照组55例不给予治疗药物,观察组服用杞菊地黄丸,分析在三个月后两组相关指标的变化。结果:观察组总有效率为78.18%,高于对照组29.09%。治疗后,观察组患者治疗后视力较治疗前改善,对照组视力较之前下降,观察组明显优于对照组。治疗后,观察组主要症状得分和角膜散光度分别为(5.02±0.86分、0.82±0.13D),均明显低于对照组(9.15±1.38分、0.99±0.18D)。(4)治疗后,观察组眼压和前房深度分别为(14.22±2.18mm Hg、2.38±0.38mm),均明显优于对照组(21.25±3.25mm Hg、1.65±0.29mm)。结论:杞菊地黄丸对早期年龄相关性白内障患者具有改善作用,并可减轻相关症状。
[Abstract]:Objective: to observe the clinical effect of Qiju Dihuang pills on early age-related cataract. Methods: from July 2015 to June 2016, 110 patients with early age-related cataract were randomly divided into two groups: the control group (55 cases) were not treated with drugs, and the observation group (55 cases) took Qiju Dihuang pills (QJD). The changes of two groups of related indexes were analyzed after 3 months. Results: the total effective rate of observation group was 78.18, higher than that of control group 29.09. After treatment, the visual acuity of the observation group was better than that of the control group, and the visual acuity of the control group was lower than that of the control group. After treatment, the scores of main symptoms and corneal astigmatism in the observation group were (5.02 卤0.86) and (0.82 卤0.13 D), respectively, which were significantly lower than those in the control group (9.15 卤1.38, 0.99 卤0.18D). (_ 4). The intraocular pressure and anterior chamber depth in the observation group were (14.22 卤2.18mm Hg,2.38 卤0.38mm), which were significantly better than those in the control group (21.25 卤3.25mm Hg,1.65 卤0.29mm). Conclusion: Qiju Dihuang pills can improve early age-related cataract patients and alleviate related symptoms.
【作者单位】：石家庄市第四医院;石家庄市第五医院;
【基金】：河北省中医药管理局科研计划项目(项目编号:2017228)
【分类号】：R276.7

【相似文献】